ELMD on NYSE
Electromed, Inc.
American electromedical and electrotherapeutic apparatus company. Summary from the record
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with EDAP TMS SA, Ceribell, Inc. or VASO Corp, or pick any stock.
- TickerELMD on NYSE1
- IndustryElectromedical & Electrotherapeutic Apparatus1
- HeadquartersNew Prague, Minnesota1
- Incorporated inMN3
- Business address500 Sixth Avenue Nw, New Prague, Mn 560713
- Filer categoryNon-accelerated filer, Smaller reporting company3
See how the biggest companies compare on our leaderboards
Electromed, Inc. (“we,” “our,” “us,” “Electromed” or the “Company”) develops, manufactures, markets and sells innovative products that provide airway clearance therapy, including the SmartVest ® Airway Clearance System (“SmartVest System”) to patients with compromised pulmonary function with a commitment to excellence and compassionate service. Our goal is to make High Frequency Chest Wall Oscillation (“HFCWO”) treatments as effective, convenient, and comfortable as possible, so our patients can breathe easier and live better with improved respiratory function and fewer exacerbations.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2026
Where the money goes
Where each dollar of revenue went, fiscal 2026
- Cost of revenue21¢$15.8M
- Research and development2¢$1.3M
- Selling, general and admin58¢$42.7M
- Income tax4¢$3.1M
- Profit15¢$11.3M
Out of $73.8M in revenue.2
Where each dollar of operating cash went, fiscal 2026
- Capital spending13¢$1.3M
- Share buybacks41¢$3.9M
- Kept or used elsewhere47¢$4.5M
Out of $9.7M of cash from operations.2
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.2
| Period ending | 2026-06-30 | 2025-06-30 |
|---|---|---|
| Net revenues | $73.8M | $64.0M |
| Cost of revenues | $15.8M | $14.0M |
| Gross profit | $57.9M | $50.0M |
| Selling, general and administrative | $42.7M | $39.3M |
| Research and development | $1.3M | $996.0K |
| Total operating expenses | $44.1M | $40.3M |
| Operating income | $13.9M | $9.7M |
| Interest income, net | $479.0K | $624.0K |
| Net income before income taxes | $14.4M | $10.3M |
| Income tax expense | $3.1M | $2.7M |
| Net income | $11.3M | $7.5M |
| Basic (in dollars per share) | $1.37 | $0.89 |
| Diluted (in dollars per share) | $1.30 | $0.85 |
| Basic (in shares) | 8.3M shares | 8.5M shares |
| Diluted (in shares) | 8.7M shares | 8.9M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.2
| Period ending | 2026-06-30 | 2025-06-30 | 2024-06-30 |
|---|---|---|---|
| Cash and cash equivalents | $20.4M | $15.3M | |
| Accounts receivable (net of allowances for credit losses of $45,000) | $29.8M | $24.7M | |
| Contract assets | $1.1M | $1.0M | |
| Inventories | $3.7M | $3.3M | |
| Prepaid expenses and other current assets | $1.2M | $392.0K | |
| Income tax receivable | $1.2M | $408.0K | |
| Total current assets | $57.4M | $45.1M | |
| Net property and equipment | $5.2M | $4.7M | |
| Finite-life intangible assets, net | $379.0K | $371.0K | $657.0K |
| Other Assets, Noncurrent | $1.3M | $1.2M | |
| Deferred income taxes | $2.0M | $2.5M | |
| Total assets | $66.3M | $53.8M | |
| Accounts payable | $2.6M | $2.7M | |
| Accrued compensation | $6.1M | $5.1M | |
| Warranty reserve | $1.9M | $1.6M | |
| Other Accrued Liabilities, Current | $1.6M | $1.1M | |
| Total current liabilities | $12.2M | $10.5M | |
| Other long-term liabilities | $66.0K | $125.0K | |
| Total liabilities | $12.3M | $10.6M | |
| Common stock, $0.01 par value per share, 13,000,000 shares authorized; 8,366,163 and 8,349,176 shares issued and outstanding, as of June 30, 2026, and June 30, 2025, respectively | $84.0K | $83.0K | |
| Additional paid-in capital | $25.3M | $21.9M | |
| Retained earnings | $28.6M | $21.2M | |
| Total shareholders equity | $54.0M | $43.2M | $44.5M |
| Total liabilities and shareholders equity | $66.3M | $53.8M | |
| Allowances for credit losses | $45.0K | $45.0K | |
| Common stock, par value (in dollars per share) | $0.01 | $0.01 | |
| Common stock, shares authorized (in shares) | 13.0M shares | 13.0M shares | |
| Common stock, shares issues (in shares) | 8.4M shares | 8.3M shares | |
| Common stock, shares outstanding (in shares) | 8.4M shares | 8.3M shares |
| Period ending | 2026-06-30 | 2025-06-30 | 2024-06-30 |
|---|---|---|---|
| Cash and cash equivalents | $20.4M | $15.3M | |
| Accounts receivable (net of allowances for credit losses of $45,000) | $29.8M | $24.7M | |
| Contract assets | $1.1M | $1.0M | |
| Inventories | $3.7M | $3.3M | |
| Prepaid expenses and other current assets | $1.2M | $392.0K | |
| Income tax receivable | $1.2M | $408.0K | |
| Total current assets | $57.4M | $45.1M | |
| Net property and equipment | $5.2M | $4.7M | |
| Finite-life intangible assets, net | $379.0K | $371.0K | $657.0K |
| Other Assets, Noncurrent | $1.3M | $1.2M | |
| Deferred income taxes | $2.0M | $2.5M | |
| Total assets | $66.3M | $53.8M | |
| Accounts payable | $2.6M | $2.7M | |
| Accrued compensation | $6.1M | $5.1M | |
| Warranty reserve | $1.9M | $1.6M | |
| Other Accrued Liabilities, Current | $1.6M | $1.1M | |
| Total current liabilities | $12.2M | $10.5M | |
| Other long-term liabilities | $66.0K | $125.0K | |
| Total liabilities | $12.3M | $10.6M | |
| Common stock, $0.01 par value per share, 13,000,000 shares authorized; 8,366,163 and 8,349,176 shares issued and outstanding, as of June 30, 2026, and June 30, 2025, respectively | $84.0K | $83.0K | |
| Additional paid-in capital | $25.3M | $21.9M | |
| Retained earnings | $28.6M | $21.2M | |
| Total shareholders equity | $54.0M | $43.2M | $44.5M |
| Total liabilities and shareholders equity | $66.3M | $53.8M | |
| Allowances for credit losses | $45.0K | $45.0K | |
| Common stock, par value (in dollars per share) | $0.01 | $0.01 | |
| Common stock, shares authorized (in shares) | 13.0M shares | 13.0M shares | |
| Common stock, shares issues (in shares) | 8.4M shares | 8.3M shares | |
| Common stock, shares outstanding (in shares) | 8.4M shares | 8.3M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.2
| Period ending | 2026-06-30 | 2025-06-30 |
|---|---|---|
| Net income | $11.3M | $7.5M |
| Depreciation | $868.0K | $1.0M |
| Impairment of intangible assets | $0 | $212.0K |
| Amortization | $208.0K | $133.0K |
| Share-based compensation expense | $2.7M | $3.1M |
| Deferred income taxes | $426.0K | -$310.0K |
| Accounts receivable | -$5.1M | -$1.3M |
| Contract assets | -$58.0K | -$317.0K |
| Inventories | -$517.0K | $175.0K |
| Prepaid expenses and other assets | -$1.0M | -$959.0K |
| Income tax receivable, net | -$760.0K | -$685.0K |
| Accounts payable and accrued liabilities | $652.0K | $1.6M |
| Accrued compensation | $992.0K | $1.2M |
| Net cash provided by operating activities | $9.7M | $11.4M |
| Expenditures for property and equipment | -$1.3M | -$262.0K |
| Expenditures for finite-life intangible assets | -$48.0K | -$44.0K |
| Net cash used for investing activities | -$1.3M | -$306.0K |
| Issuance of common stock upon exercise of options | $965.0K | $398.0K |
| Taxes paid on net share settlement of stock awards | -$249.0K | -$2.3M |
| Repurchase of common stock | -$3.9M | -$10.0M |
| Net cash used for financing activities | -$3.2M | -$11.9M |
| Net increase (decrease) in cash | $5.2M | -$793.0K |
| Property and equipment and intangible asset acquisitions in accounts payable | $106.0K | $107.0K |
| Taxes owed on net share settlement of stock awards in accrued liabilities | $73.0K | $27.0K |
| Demonstration equipment transferred between inventory and property and equipment | $135.0K | $238.0K |
| Issuance of common stock upon the vesting of performance-based stock units | $0 | $1.0K |
No quarter-by-quarter statement was filed.
Leadership
Who has led Electromed, Inc., and when. Pick a name to see everywhere that person has worked.
Chief financial officer
Chief operating officer
- Chief executive officerJames L. Cunniff Jul 5, 2023 to now13
- Chief executive officerKathleen Skarvan Dec 4, 2012 to Mar 6, 202314
- Chief executive officerRobert D. Hansen Aug 12, 2010 to Dec 21, 201115
- PresidentJames L. Cunniff Jul 5, 2023 to now13
- PresidentKathleen Skarvan Nov 18, 2015 to Mar 6, 202316
- Chief financial officerMichelle C. Wirtz Jun 7, 2022 to Jul 6, 202217
- Chief financial officerBradley M. Nagel Nov 16, 2022 to now18
- Chief financial officerMichael Joseph Maccourt May 28, 2020 to Jul 6, 202119
- Chief financial officerKathleen Skarvan Jul 6, 2015 to Jul 6, 201520
- Chief financial officerJeremy T. Brock May 31, 2012 to May 26, 202021
- Chief financial officerTerry M. Belford Aug 12, 2010 to Jan 3, 201122
- Chief operating officerJames J. Cassidy Jun 3, 2011 to Feb 24, 201223
Board members and other officers (20)
- Chief Commercial OfficerChristopher G. Holland Feb 25, 2022 to Jul 6, 202224
- Financial ControllerJeremy T. Brock Aug 17, 2011 to Aug 17, 201125
- Board memberJames L. Cunniff Jul 5, 2023 to now13
- Board memberAndrew Summers Aug 16, 2022 to now26
- Board memberJoseph L. Galatowitsch Nov 22, 2021 to now27
- Board memberKathleen A. Tune Nov 22, 2021 to now28
- Board memberAndrea M. Walsh Nov 23, 2020 to now29
- Board memberGregory Fluet Aug 19, 2019 to now30
- Board memberJohn L. Erb Aug 19, 2019 to Dec 4, 201931
- Board memberKathleen Skarvan Jul 11, 2014 to now32
- Board memberA. Jones Lee Sep 5, 2014 to Dec 5, 202233
- Board memberStan K. Erickson Dec 1, 2014 to now34
- Board memberWilliam Eckles Jul 28, 2011 to Dec 4, 201835
- Board memberCraig N. Hansen Aug 12, 2010 to Aug 7, 201336
- Board memberGeorge H. Winn Aug 12, 2010 to Dec 3, 202037
- Board memberNoel D. Collis Aug 12, 2010 to Aug 12, 201038
- Board memberRobert D. Hansen Aug 12, 2010 to Dec 21, 201115
- Board memberThomas M. Hagedorn Aug 12, 2010 to Feb 24, 201239
- Board memberDarrel L. Kloeckner Nov 8, 2010 to May 22, 201240
- Board memberStephen H. Craney Nov 8, 2010 to May 19, 202141
Timeline
Filings
182 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 37 major events, 74 insider forms, 16 large holders, 35 other. The latest 20:
- Sep 29, 2026DEF 14A EDGAR
- Sep 29, 2026DEFA14A EDGAR
- Sep 29, 2026ARS EDGAR
- Sep 3, 20264 EDGAR
- Sep 3, 20264 EDGAR
- Aug 25, 20268-K EDGAR
- Aug 25, 202610-K EDGAR
- Jul 2, 20264 EDGAR
- Jun 9, 20264 EDGAR
- Jun 8, 2026144 EDGAR
- Jun 8, 20264 EDGAR
- Jun 4, 2026144 EDGAR
- May 29, 2026SD EDGAR
- May 19, 20264 EDGAR
- May 15, 2026144 EDGAR
- May 12, 202610-Q EDGAR
- May 12, 20268-K EDGAR
- Apr 1, 2026UPLOAD EDGAR
- Mar 26, 2026SCHEDULE 13G/A EDGAR
- Mar 25, 2026CORRESP EDGAR
The 182 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
20 open-market trades by officers, directors and large owners since October 2021: 3 buys and 17 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | Cunniff James L.CEO and President | Sale | 9,700 | $36.51 | $354.1K | Form 4 |
| Jun 4, 2026 | Nagel Bradley M.Chief Financial Officer | Sale | 11,801 | $36.35 | $429.0K | Form 4 |
| May 15, 2026 | SKARVAN KATHLEENDirector | Sale | 40,000 | $35.48 | $1.4M | Form 4 |
| Sep 11, 2025 | Summers AndrewDirector | Sale | 3,153 | $24.42 | $77.0K | Form 4 |
| Sep 10, 2025 | Summers AndrewDirector | Sale | 62,561 | $24.32 | $1.5M | Form 4 |
| Feb 24, 2025 | Summers AndrewDirector | Sale | 50,751 | $27.30 | $1.4M | Form 4 |
| Feb 21, 2025 | Summers AndrewDirector | Sale | 25,451 | $28.21 | $717.9K | Form 4 |
| Feb 20, 2025 | Summers AndrewDirector | Sale | 35,273 | $28.83 | $1.0M | Form 4 |
| Feb 18, 2025 | SKARVAN KATHLEENDirector | Sale | 43,954 | $29.27 | $1.3M | Form 4 |
| Feb 14, 2025 | SKARVAN KATHLEENDirector | Sale | 32,629 | $32.12 | $1.0M | Form 4 |
| Dec 5, 2024 | Summers AndrewDirector | Sale | 37,404 | $28.15 | $1.1M | Form 4 |
| Dec 4, 2024 | Summers AndrewDirector | Sale | 12,731 | $29.98 | $381.7K | Form 4 |
| Dec 3, 2024 | Summers AndrewDirector | Sale | 35,436 | $30.18 | $1.1M | Form 4 |
| Dec 2, 2024 | Summers AndrewDirector | Sale | 17,463 | $30.09 | $525.5K | Form 4 |
| Nov 19, 2024 | SKARVAN KATHLEENDirector | Sale | 107,547 | $27.95 | $3.0M | Form 4 |
| Nov 18, 2024 | SKARVAN KATHLEENDirector | Sale | 42,453 | $28.16 | $1.2M | Form 4 |
| Mar 1, 2024 | Cunniff James L.CEO and President | Buy | 9,000 | $15.25 | $137.2K | Form 4 |
| Dec 14, 2023 | Summers AndrewDirector | Buy | 28,797 | $10.50 | $302.4K | Form 4 |
| Nov 21, 2023 | Cunniff James L.CEO and President | Buy | 1,000 | $10.56 | $10.6K | Form 4 |
| Jul 12, 2023 | SKARVAN KATHLEENDirector | Sale | 1,107 | $10.83 | $12.0K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- VANGUARD GROUP INCSCHEDULE 13G/A, 2 filings Jul 29, 2025 to Mar 26, 202642
- Andrew SummersSCHEDULE 13D/A, 1 filing Feb 24, 202543
- Kathleen SkarvanSC 13D/A, 4 filings Jul 11, 2022 to Nov 21, 202444
- George H. WinnSC 13G/A, 2 filings Feb 14, 2024 to Nov 13, 202445
- Radoff Bradley LouisSC 13G/A, 3 filings Feb 14, 2023 to Nov 12, 202446
- PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.SC 13G/A, 2 filings Feb 14, 2022 to Feb 13, 202347
- Summers Value Fund LPSC 13D/A, 1 filing Jul 25, 202248
- Radoff Family FoundationSC 13G, 1 filing May 26, 202249
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16SEC EDGARKathleen Skarvan, President
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26SEC EDGARAndrew Summers, Board member
- 27SEC EDGARJoseph L. Galatowitsch, Board member
- 28SEC EDGARKathleen A. Tune, Board member
- 29SEC EDGARAndrea M. Walsh, Board member
- 30SEC EDGARGregory Fluet, Board member
- 31SEC EDGARJohn L. Erb, Board member
- 32SEC EDGARKathleen Skarvan, Board member
- 33SEC EDGARA. Jones Lee, Board member
- 34SEC EDGARStan K. Erickson, Board member
- 35SEC EDGARWilliam Eckles, Board member
- 36SEC EDGARCraig N. Hansen, Board member
- 37SEC EDGARGeorge H. Winn, Board member
- 38SEC EDGARNoel D. Collis, Board member
- 39SEC EDGARThomas M. Hagedorn, Board member
- 40SEC EDGARDarrel L. Kloeckner, Board member
- 41SEC EDGARStephen H. Craney, Board member
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49